The collateral damage from Monash IVF's colossal embryo bungles
The next part of the script unusually involves activists calling for enhanced regulation or better laws.
Advocates are also lobbying for all those who use assisted reproductive technology to have their babies DNA tested, which, if implemented, could uncover if other mistakes have gone undetected.
And no scandal is complete without a politician or two making some hay by grabbing a microphone and castigating the culprits.
Victorian Health Minister Mary-Anne Thomas was the first to step up this week, calling the embryo mix-up 'completely unacceptable'.
'It's very clear to me that the board of Monash IVF needs to have a very good look at what's going on,' Thomas said.
Loading
'Clearly their clinical governance standards are not what they should be.'
But amid the outrage there is another group that will also sustain collateral damage – the shareholders – although sympathy for this group will be way more muted.
They have seen the share price of Monash IVF plunge after the first incident was revealed in April and after the company cut its 2025 full-year profit guidance by 11 per cent.
It took another dive this week when the second implant bungle was revealed, taking this calendar year's stock performance down by 50 per cent.
The shares kicked up by 5.7 per cent on Thursday on the news of the departing chief, but this represents a small recovery.
Enter the investment bank analysts who use their sophisticated models to provide commentary on the impacts of these types of events on a company's market share and future earnings.
In the case of Monash, their opinions run the gamut of possibilities.
RBC Capital markets suggests that the fallout from the original bungle in Monash's Queensland clinic would confine the loss of market share to that state, and not impact too heavily on other state operations. But given there have now been two separate embryo transfer incidents in different states, it believes there is risk of a greater impact of a spread of reputational damage and market share losses. It has a negative stance on the stock.
Macquarie Equities has a somewhat different view. It acknowledges the reputational damage, but says the stock is oversold and represents a good buying opportunity.
You could characterise its advice as 'don't throw the baby out with the bathwater'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ABC News
3 hours ago
- ABC News
The IVF industry is under the microscope after Monash IVF apologised for a second embryo bungle. How rare is a mistake?
The IVF industry is under the microscope after major fertility provider Monash IVF apologised for a second embryo bungle. Days after the company told the stock market about the latest case, its chief executive officer resigned. It followed revelations in April that one of Monash IVF's Brisbane patients had been mistakenly implanted with another woman's embryo in 2023 and gave birth to a baby who had no genetic links to her later that year. An independent review is ongoing. Approximately 20,000 babies are born from IVF treatment in Australia every year, according to the Australian and New Zealand Assisted Reproduction Database. So, what is the process, what are the checks and balances, and how rare are such bungles? In vitro fertilisation — or IVF — is one of the most common assisted reproductive technology procedures (ART). The process involves collecting a donor or patient's eggs, then fertilising them with sperm in a Petri dish in a lab. A fertilised egg — known as an embryo — is then implanted into the woman's uterus. Fertility educator and IVF patient advocate Lucy Lines has previously worked as an embryologist — a scientist who specialises in developing embryos. She says whenever eggs, sperm or embryos are moved in the lab, the dishes and paperwork are all labelled with the patient's name, their ID number, and date of birth. In some labs, they are allocated a colour code as well, she says. "At minimum, there are three points of reference for each client inside the lab," she says. "So then when anything is moved from one dish or tube to another dish or tube, a second embryologist will come along and audibly repeat [the patient's name, date of birth, and the ID number]. "That is the historical way that it was done. "In some labs they've added an extra level, a barcode that requires a scanner to read the barcode, or in some other labs they have an RFID (Radio Frequency Identification) label, which has an auto-reader on the bench top or workspace and that reader will sound if there are things on that bench that don't match each other." It varies. There are more than 40 "different pieces of legislation" governing ART and IVF across the country, according to the Fertility Society of Australia and New Zealand (FSANZ). For example, laws to regulate ART providers in Queensland only passed parliament last year. By comparison, Victoria has had laws in place for years. FSANZ's Reproductive Technology Accreditation Committee (RTAC) is responsible for setting performance standards and granting licences to fertility providers across the country. The society and RTAC are currently operated on a "volunteer basis by professionals within the sector who have taken on additional responsibilities". FSANZ is calling for the establishment of RTAC as an independent statutory authority to "strengthen oversight and trust in the sector". That is backed by the Victorian Health Minister Mary-Anne Thomas who said yesterday it was concerning that the body that currently accredits fertility care providers is made up of fertility care providers. Yesterday, all Australian states and territories agreed to undertake a review into the implementation of an independent verification body for fertility providers. There are growing calls for national fertility legislation to replace the "fragmented" state and territory laws and provide "consistent, enforceable standards". IVF activist Anastasia Gunn is among those pushing for change. "We're asking for federal legislation of the industry, which the industry itself are asking for that," she says. "We're asking for a federal donor conception registry [as] historically gametes and embryos have been moved interstate. "Donor conceived people have a right to know their biological and medical history if they choose to. "We're choosing to ask for external regulation of the industry." No, there is no licensing or registration of embryologists in Australia — unlike other professions such as doctors and nurses. It is something the FSANZ would like to see changed. "We continue to advocate for robust professional recognition of embryologists in Australia — both to uphold standards and to protect the public," a FSANZ spokesperson said in a statement. "The medical laboratory professionals in Australia chose to set up this self-regulated scheme because the Australian Government decided not to include Medical Scientists and Technical Officers in the professions covered by the Australian Health Practitioner Regulation Agency (AHPRA) when it was established in 2010. "Most comparable countries do have formal regulation of Medical Scientists and Technical Officers to protect the public and set minimum standards for ongoing assessment of competency and continuing professional development. "It would require the Australian Government to legislate mandatory registration." The industry insists they are rare. But others — such as Sydney Law School lecturer Christopher Rudge — acknowledge it is also difficult to know without specific data. "The recent history of IVF mistakes and errors is somewhat clouded by reported settlements, private settlements, so it is hard to know the true frequency of these errors," Dr Rudge told the ABC earlier this week. Monash IVF is a publicly listed company, which means it has "disclosure obligations". Over the past two months, it has made statements to the ASX — and its shareholders — about the two embryo incidents. However the ASX also issued Monash IVF a 'please explain' about the timing of the Brisbane announcement — which came weeks after the company said it became aware of the mix-up. Monash IVF's chief financial officer said the company did not expect the bungle would affect its share price "as it was an isolated incidence of human error". The company's share price plummeted from $1.08 to 69 cents after the Brisbane bungle was made public in April. Ms Lines says it was complex. "My only answer is, if you're looking down the barrel of IVF, arm yourself with the knowledge of what's actually involved … so that you can empower yourself to ask the questions that you need the answers to," she says.
Sydney Morning Herald
4 hours ago
- Sydney Morning Herald
Government relying on Latham for workers' compensation reforms
Maverick MP Mark Latham has indicated he is open to supporting the government's workers' compensation reforms, but only with a raft of amendments, while the Coalition hopes it can roll back a tightening of criteria for long-term payouts. The public accountability and works committee received a confidential briefing from Treasurer Daniel Mookhey and bureaucrats on Thursday, aiming to allay concerns about the drivers of Labor's plan to curtail access to compensation for psychological injuries. Two years after Premier Chris Minns refused to work with Latham, the dynamics of the seven-person committee have left the rogue MP with the casting vote on whether the legislation will return for a vote during budget week, in late June, or whether the inquiry continues indefinitely. After the government's reforms were referred for a second interrogation by a parliamentary inquiry, their fate hinged in part on Thursday's briefing. Mookhey has said that without reform the system will collapse while rising premiums push businesses under. But the Coalition, Greens and upper house independents have questioned government efforts to jam the legislation through parliament, particularly given a key plank of the reforms would cut off compensation for some of the state's sickest workers. Loading The second inquiry was established to allow crossbenchers to interrogate assumptions underpinning Mookhey's reforms. A public hearing will take place on Tuesday, a month after a snap inquiry heard only 27 of the hundreds of employees impaired by workplace psychological injury each year would be eligible to claim long-term benefits under the minimum 31 per cent Whole of Person Impairment (WPI) rating proposed by the government. Describing Thursday's briefing as 'fairly useful', Latham said some aspects of the workers' compensation reforms introduced by the Victorian Labor government in March 2024 were superior as they dealt with the long-term structural problem of nebulous claims, where the link between injury and a claimant's work is unclear. While he would prefer the bill to be voted on by June's end, Latham said he would not rubber stamp the legislation, seeking to amend it to include the 'best of the Victorian reforms', including tightening definitions around bullying and harassment to restrict claims.
The Age
5 hours ago
- The Age
Government relying on Latham for workers' compensation reforms
Maverick MP Mark Latham has indicated he is open to supporting the government's workers' compensation reforms, but only with a raft of amendments, while the Coalition hopes it can roll back a tightening of criteria for long-term payouts. The public accountability and works committee received a confidential briefing from Treasurer Daniel Mookhey and bureaucrats on Thursday, aiming to allay concerns about the drivers of Labor's plan to curtail access to compensation for psychological injuries. Two years after Premier Chris Minns refused to work with Latham, the dynamics of the seven-person committee have left the rogue MP with the casting vote on whether the legislation will return for a vote during budget week, in late June, or whether the inquiry continues indefinitely. After the government's reforms were referred for a second interrogation by a parliamentary inquiry, their fate hinged in part on Thursday's briefing. Mookhey has said that without reform the system will collapse while rising premiums push businesses under. But the Coalition, Greens and upper house independents have questioned government efforts to jam the legislation through parliament, particularly given a key plank of the reforms would cut off compensation for some of the state's sickest workers. Loading The second inquiry was established to allow crossbenchers to interrogate assumptions underpinning Mookhey's reforms. A public hearing will take place on Tuesday, a month after a snap inquiry heard only 27 of the hundreds of employees impaired by workplace psychological injury each year would be eligible to claim long-term benefits under the minimum 31 per cent Whole of Person Impairment (WPI) rating proposed by the government. Describing Thursday's briefing as 'fairly useful', Latham said some aspects of the workers' compensation reforms introduced by the Victorian Labor government in March 2024 were superior as they dealt with the long-term structural problem of nebulous claims, where the link between injury and a claimant's work is unclear. While he would prefer the bill to be voted on by June's end, Latham said he would not rubber stamp the legislation, seeking to amend it to include the 'best of the Victorian reforms', including tightening definitions around bullying and harassment to restrict claims.
